CD4, and granzyme B but which did not express TRBC1 chain (a marker for expression of a T-cell antigen receptor constant beta chain; uniform positivity or negativity indicates clonality) or CD8.

This study provides evidence that single-cell multi-omics profiling can reveal key regulators of HIV-1 persistence and early immune dysregulation, particularly implicating KLF2 and Th17 cells as major ...

Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced the publication of data supporting the effective use of its high-density microarray patch ...

A group of Berlin researchers in collaboration with international scientists have found differences in heart inflammation ...

StockNews.com started coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Free Report) in a research report sent to investors on Sunday. The brokerage issued a sell rating on the biotechnology ...

Culver City, California Saturday, March 1, 2025, 17:00 Hrs [IST] ...

The FDA granted RMAT designation to nogapendekin alfa and CAR-NK for reversing lymphopenia in patients with cancer, with ...

Genocea Biosciences (NASDAQ:GNCA – Get Free Report) and Kodiak Sciences (NASDAQ:KOD – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the ...

Scientists explored the differences in heart inflammation caused by COVID-19, anti-COVID-19 vaccines, and other viral ...